1. DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn's and Colitis Organisation study. (16th January 2018) Authors: Kopylov, U; Verstockt, B; Biedermann, L; Sebastian, S; Pugliese, D; Sonnenberg, E; Steinhagen, P R; Arebi, N; Ron, Y; Kucharzik, T; Roblin, X; Ungar, B; Bar-Gil Shitrit, A; Ardizzone, S; Molander, P; Coletta, M; Peyrin-Biroulet, L; Bossuyt, P; Avni-Biron, I; Tsoukal, E I Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Monocyte-derived dendritic cells from Crohn's disease patients exhibit decreased ability to activate T helper type 17 responses in memory cells. (9th June 2014) Authors: Nieminen, J K; Sipponen, T; Färkkilä, M; Vaarala, O Journal: Clinical and experimental immunology Issue: Volume 177:Number 1(2014:Jul.) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P467 Therapeutic drug monitoring of biologics in Inflammatory Bowel Disease: Nordic survey on implementation and barriers in clinical practice. (21st January 2022) Authors: Bjørlykke, K; Jahnsen, J; Brynskov, J; Molander, P; Eberhardson, M; Davidsdottir, L G; Sipponen, T; Hjortswang, H; Langholz, E; Jørgensen, K K; Steenholdt, C Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P600 Ustekinumab for Crohn's disease: a nationwide real-life observational cohort study from Finland. (25th January 2019) Authors: Eberl, A; Hallinen, T; af Björkesten, C-G; Heikkinen, M; Hirsi, E; Kellokumpu, M; Koskinen, I; Moilanen, V; Nielsen, C; Nuutinen, H; Suhonen, U-M; Utriainen, K; Vihriälä, I; Soini, E; Wennerström, C; Nissinen, R; Borsi, A; Koivunen, M; Tillonen, J; Sipponen, T Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P629 Real-life treatment persistence and treatment outcomes of Finnish patients with Inflammatory Bowel Disease receiving vedolizumab as first-line biological treatment. (30th January 2023) Authors: Ylisaukko-oja, T; Af Björkesten, C G; Erbel, A; Nuutinen, H; Jussila, A; Molander, P; Koskela, R; Blomster, T; Pajala, M; Ilus, T; Haiko, P; Kovac, B; Silvola, S; Smith, S; Jokelainen, J; Sipponen, T Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗